Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database
Articolo
Data di Pubblicazione:
2018
Citazione:
Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database / Del Bene, G; Calabro, F; Giannarelli, D; Plimack, Er; Harshman, Lc; Yu, Ey; Crabb, Sj; Pal, Sk; Alva, As; Powles, T; De Giorgi, U; Agarwal, N; Bamias, A; Ladoire, S; Necchi, A; Vaishampayan, Un; Niegisch, G; Bellmunt, J; Baniel, J; Galsky, Md; Sternberg, Cn. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 8:(2018). [10.3389/fonc.2018.00463]
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Del Bene, G; Calabro, F; Giannarelli, D; Plimack, Er; Harshman, Lc; Yu, Ey; Crabb, Sj; Pal, Sk; Alva, As; Powles, T; De Giorgi, U; Agarwal, N; Bamias, A; Ladoire, S; Necchi, A; Vaishampayan, Un; Niegisch, G; Bellmunt, J; Baniel, J; Galsky, Md; Sternberg, Cn
Link alla scheda completa:
Pubblicato in: